Skip to main content
. 2017 Mar 21;7:44823. doi: 10.1038/srep44823

Table 3. Univariate and multivariate Cox regression analyses of patient and tumour factors with DFS and OS in Stage III-IVa patients.

  P value DFS P value OS
HR (95% CI) HR (95% CI)
Univariate analysis
sTIL (>10%) 0.031 0.615 (0.395–0.957) 0.007 0.544 (0.349–0.850)
iTIL (>10%) 0.620 0.895 (0.577–1.389) 0.557 0.875 (0.561–1.366)
iTIL (>20%) 0.046 0.309 (0.097–0.980) 0.061 0.331 (0.104–1.052)
sCD4 (>10%) 0.521 0.787 (0.379–1.635) 0.399 0.730 (0.351–1.518)
sCD8 (>10%) 0.078 0.654 (0.408–1.048) 0.036 0.599 (0.371–0.968)
iCD8 (>10%) 0.329 0.780 (0.474–1.284) 0.314 0.767 (0.458–1.285)
sFoxp3 (>10%) 0.182 0.260 (0.036–1.878) 0.160 0.241 (0.033–1.749)
Sex 0.336 0.710 (0.354–1.425) 0.449 0.868 (0.600–1.254)
Age 0.409 1.202 (0.777–1.859) 0.340 1.238 (0.799–1.919)
Grade 0.922 0.980 (0.658–1.461) 0.804 0.950 (0.633–1.426)
Vessel invasion 0.596 1.128 (0.723–1.760) 0.366 1.230 (0.786–1.925)
Nerve invasion 0.322 1.249 (0.804–1.939) 0.245 1.300 (0.836–2.021)
Lymph node metastasis 0.101 0.521 (0.239–1.137) 0.208 0.606 (0.278–1.321)
Site 0.011 0.620 (0.429–0.896) 0.013 0.622 (0.427–0.905)
Smoking 0.295 0.792 (0.513–1.224) 0.296 0.791 (0.510–1.228)
Multivariate analysis        
sTIL (>10%) 0.081 0.671 (0.428–1.051) 0.032 0.535 (0.303–0.947)
iTIL (>20%) 0.056 0.322 (0.101–1.028) 0.071 0.341 (0.106–1.095)
sCD8 (>10%)     0.785 1.091 (0.584–2.040)
Site 0.038   0.032  
 Middle 0.233 0.557 (0.213–1.457) 0.144 0.479 (0.178–1.285)
 Lower 0.036 0.359 (0.138–0.934) 0.022 0.311 (0.114–0.848)

DFS, disease free survival. OS, disease specific overall survival. HR, hazard ratio. CI, confidence interval. sTIL, stromal infiltrating lymphocytes. iTIL, intratumoural infiltrating lymphocytes. sCD4, CD4+ stromal infiltrating lymphocytes. sCD8, CD8+ stromal infiltrating lymphocytes. iCD8, CD8+ intratumoural infiltrating lymphocytes. sFoxp3, Foxp3+ stromal infiltrating lymphocytes. iFoxp3, Foxp3+ intratumoural infiltrating lymphocytes.